PGRP-I β Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of PGRP-I β monoclonal antibodies for research focused on understanding immune system responses. PGRP-I β Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PGRP-I β (Peptidoglycan Recognition Protein I beta) plays a crucial role in the innate immune response by recognizing bacterial peptidoglycans, which are essential components of bacterial cell walls. PGRP-I β is involved in the modulation of immune signaling pathways, contributing to the host's defense against microbial infections. Understanding PGRP-I β function is vital for elucidating mechanisms of immune response and developing therapeutic strategies against bacterial pathogens. Researchers can utilize specific monoclonal antibodies to investigate PGRP-I β expression patterns across different tissues and cell types. Advanced imaging techniques combined with PGRP-I β monoclonal antibodies enable detailed visualization of protein localization and interactions. Extensive experimental protocols incorporating PGRP-I β monoclonal antibodies support reproducible research outcomes. Santa Cruz Biotechnology monoclonal antibodies for PGRP-I β research contribute to advancing our understanding of immune system regulation and potential therapeutic applications.